Recent Finacing
Recent Raise
SciTech Development is a Detroit-based clinical-stage oncology company developing ST-001 nanoFenretinide, a nanotechnology-enabled cancer drug.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at SciTech Development.
